AMG 714 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vitiligo
Conditions
Vitiligo
Trial Timeline
Dec 11, 2020 → Apr 2, 2025
NCT ID
NCT04338581About AMG 714 + Placebo
AMG 714 + Placebo is a phase 2 stage product being developed by Amgen for Vitiligo. The current trial status is completed. This product is registered under clinical trial identifier NCT04338581. Target conditions include Vitiligo.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04338581 | Phase 2 | Completed |
| NCT02637141 | Phase 2 | Completed |
| NCT02633020 | Phase 2 | Completed |
Competing Products
20 competing products in Vitiligo